Corgenix Gets Shot Of Life With ELITech Investment, Worth Up To $3 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Denver-based in vitro diagnostics firm Corgenix Medical anticipates an investment from the ELITech Group will allow the company to refocus on delayed initiatives and explore new platforms, according to CFO Bill Chritchfield